Clinical, Technology and Physics



Leslie E. Botnick, MD – Chief Medical Officer and Co-Founder


A board certified Radiation Oncologist practicing at The Center for Radiation Therapy of Beverly Hills, Dr. Botnick is Co-Founder and Chief Medical Officer of Vantage Oncology.  In addition, he is the Chief Executive Officer and Founder of Valley Radiotherapy Associates Medical Group.  Previously at the Beth Israel Hospital in Boston, Dr. Botnick was Medical Director of Radiation Oncology.

With more than 40 publications on Breast Cancer, Hodgkin’s disease, Head and Neck Cancer and Hematopoietic Stem Cell Repair, he is named as a leading physician for the treatment of Breast Cancer in Good Housekeeping Magazine and listed in Who’s Who of Doctors in America.  In addition, Dr. Botnick is associated with several Health Systems throughout Los Angeles, Orange and Riverside counties in California, including the nationally renowned John Wayne Cancer Institute.  His areas of expertise include: Breast, Prostate, Lung, Head and Neck, Pancreatic, and Colorectal Cancer as well as Hodgkin’s and Non-Hodgkin’s Lymphoma. 

At Metropolitan Hospital in New York, he served an internship in internal medicine and did his residency at the Harvard Joint Center for Radiation Therapy in Boston where he later became Chief Resident.  Dr. Botnick earned a Bachelors of Arts Degree from Brooklyn College followed by a Medical Degree from New York Medical College.


 
Leslie E. Botnick, MD – Chief Medical Officer

Christopher M. Rose, MD, FACR – Chief Technology Officer

Dr. Christopher Rose is a board certified Radiation Oncologist and serves as Medical Director of The Center for Radiation Therapy of Beverly Hills.  Dr. Rose is both the Technical and Associate Director of Valley Radiotherapy Associates Medical Group and a Co-Founder of Vantage Oncology.  He received his B.S. from the Massachusetts Institute of Technology and M.D. from Harvard Medical School.  Upon graduation, he served an internship and residency in Internal Medicine at the Beth Israel Hospital in Boston, followed by a residency in Radiation Oncology at the Harvard Joint Center for Radiation Therapy.  Dr. Rose was a Visiting Clinical Scientist at the Institute for Cancer Research, Royal Marsden Hospital, University of London in Great Britain.  He was an Assistant Professor of Radiation Oncology at Harvard Medical School. Dr. Rose was Chairman of the Board of Directors and President of the American Society of Therapeutic Radiology and Oncology, the professional society of Radiation Oncology. 

Dr. Rose is Past President of the Council of Affiliated Regional Radiation Oncology Societies of the American College of Radiology, Past President of the California Radiation Oncology Society, and Counselor of the American College of Radiology.  He was the Expert Physician reviewer for radiation oncology for the California Medicare Carrier and advisor to the Health Care Financing Agency Clinical Practice Expense Panel.  He is currently a member of the Medicare Coverage Advisory Commission and Vice Chair of the NCI-sponsored Quality Research in Radiation Oncology Study. Dr. Rose has published more than 50 articles on the treatment of Prostate Cancer, Breast Cancer, Head and Neck Cancer and physico-chemical methods of radiation sensitization.  He is one of three radiation oncologists who received the Donald Coffey Clinician Scientist Award of the Prostate Cancer Foundation. He is the 2008 Gold Medalist of the American Society of Therapeutic Radiology and Oncology. He is listed in Best Doctors in America. Areas of expertise include Prostate, Breast, Skin, Rectal, Esophageal, and Lung Cancer as well as Bone Metastases.


 
Christopher M. Rose, MD, FACR – Chief Technology Officer
 

Charles Smith – Sr. Vice President of Clinical Technologies and Services

Charles joined the Vantage management team as Sr. Vice President of Clinical Technologies and Services in October of 2013. His responsibilities include managing the clinical technology footprint of the Vantage network, driving operating efficiencies through best practices and standardization, and participating in key strategic initiatives related to physician leadership and partnerships with payers.

Before joining Vantage Oncology, Dr. Smith has worked as an industry consultant and was Chief Operating Officer at ProCure, a private equity backed business providing capital and professional management services to healthcare providers. Before joining ProCure, Charles was a member of the management team at McKesson Specialty Health and The US Oncology Network for more than 9 years serving in multiple roles and led the radiation oncology and diagnostic imaging services for nearly 5 years as VP of Cancer Center Services. Prior to joining US Oncology, Dr. Smith worked as a member of the clinical faculty in the department of radiation oncology at Northwestern University in Chicago. He earned a PhD from the University of Nebraska, an MBA from Texas A&M University, and is a diplomate of the American Board of Radiology.

 
Charles Smith – Sr. Vice President of Clinical Technologies and Services

Eliot S. Levitt – Vice President of Informatics

Mr. Levitt works closely with Vantage Oncology's clinical department to provide technology that supports the practice of outcomes-based medicine. He has more than 14 years of progressive experience in technology development. Mr. Levitt previously held engineering leadership positions at DoubleClick Inc., most recently serving as Vice President of Engineering for Diameter, DoubleClick's research division. He also served as Director of Project Management and Technical Consulting Services at WebVision Inc., an e-commerce technology infrastructure company. Mr. Levitt has a BA from the Massachusetts Institute of Technology.

 
Eliot S. Levitt – Vice President of Informatics


Beatrice Mautner, RN, MSN, OCN® – Vice President, Nursing and Clinical Services


Beatrice Mautner has rejoined Vantage Oncology in 2011 as Vice-President Nursing and Clinical Services, to lead the development and implementation of clinical improvement strategies and the Vantage Oncology Clinical Research and Patient Outcomes program. Beatrice brings to Vantage 30 years nursing, radiation oncology and management experience. She was the Clinical Nursing Coordinator for Valley Radiotherapy Associates and then helped set up the initial clinical programs for VantageOncology as the Vice President of Clinical Programs. Most recently, Beatrice spent 7 years in the Scientific Affairs Department at Amgen, Inc.
 
Ms. Mautner is past chair of the ASTRO Nursing Committee and is a member of ASTRO, ASCO and ONS. She has published a number of oncology nursing related articles. Beatrice received a Bachelor of Science in Nursing with Magna Cum Laude Honors from the Universidad Católica in Santiago, Chile and a Master of Science in Nursing from the University of Phoenix.

 
 Beatrice Mautner – Vice President, Nursing and Clinical Services